Closes
14 Nov 2026
5 days left
EMD
—
Quantity
153
AI summary
Indian Army (Ministry of Defence) is buying INJ BIOVIC 90 MG (SODIUM HYALURONATE), INJ POLATUZUMAB 140MG, Inj Anti-Hemophilic 500 UNIT (Factor-VI (quantity 153) in South West Delhi, Delhi. Bids close on 14 Nov 2026.
Written automatically from the public tender details. Always check the bid document before you bid.
Tender details
- Ministry
- Ministry of Defence
- Department
- Department of Military Affairs
- Organisation
- Indian Army · South West Delhi
- Location
- South West Delhi, Delhi
- Bid start
- 24 Oct 2026, 09:10 am
- Bid end
- 14 Nov 2026, 10:00 am
- Bid opening
- 15 Nov 2026, 10:00 am
- Reverse auction
- Yes
- Quantity
- 153
- Estimated value
- ₹20,61,101
- ePBG
- 3%
- MSE preference
- Yes
- Make in India preference
- Yes
Items (3)
- INJ BIOVIC 90 MG (SODIUM HYALURONATE)
- INJ POLATUZUMAB 140MG
- Inj Anti-Hemophilic 500 UNIT (Factor-VI
Can you bid on this tender?
The bid document sets conditions that decide whether your bid is even opened. Mitra has read it for you.
- Minimum turnover required
- Stated in the bid
- Years of experience required
- Stated in the bid
- MSE / startup relaxation
- Stated in the bid
- Documents you must upload
- Stated in the bid
- Your eligibility check against your company
- Stated in the bid
- Original bid document (PDF)
- Stated in the bid
Why unlock?
- ★Most GeM bids are rejected for a missing document or a turnover shortfall, not price.
- ★Check in one minute instead of reading a 30-page PDF.
- ★One won order pays for years of Mitra.
Frequently asked questions
What is the last date to bid?
Bids close on 14 Nov 2026, 10:00 am (IST).
Is EMD required for this tender?
The bid document does not state EMD clearly.
Who can bid?
MSE purchase preference applies. The bid document sets turnover/experience conditions; Mitra shows the exact figures and checks your eligibility.
Source: Government e-Marketplace (GeM). Last updated 07 Nov 2026, 10:50 pm.